Virologic Response and Safety of Ibuzatrelvir, a Novel SARS-CoV-2 Antiviral, in Adults With COVID-19
Mortezavi et al., Clinical Infectious Diseases, doi:10.1093/cid/ciae529
https://c19early.org/mortezavi.html